CURRENT STUDIES

Learn more about our upcoming and ongoing research opportunities.

FALCON Ulcerative Colitis Study

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of study drug (GS-4875) in Subjects with…

>> Learn More >> Apply to Volunteer

Tuscany II Ulcerative Colitis Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of study drug…

>> Learn More >> Apply to Volunteer

Celiac Disease Study

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide for…

>> Learn More >> Apply to Volunteer

Lucent 1 & Lucent 2 Studies

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizmab in Conventional-Failed and Biologic-Failed Patents…

>> Learn More >> Apply to Volunteer

U-Exceed Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More >> Apply to Volunteer

U-Excel Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More >> Apply to Volunteer

FALCON Ulcerative Colitis Study

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of study drug (GS-4875) in Subjects with…

>> Learn More

Tuscany II Ulcerative Colitis Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of study drug…

>> Learn More

Celiac Disease Study

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide for…

>> Learn More

Lucent 1 & Lucent 2 Studies

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizmab in Conventional-Failed and Biologic-Failed Patents…

>> Learn More

U-Exceed Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More

U-Excel Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects…

>> Learn More